ResearcherNo recent work listed
Peter Würl
Matched on OpenAlex author ID A5082873482.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Collaborators
- 4
2011: 2 papers · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper
Papers 3
- CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-16-0058↗
- Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma. Last author DOI 10.1097/mpa.0b013e3181f95104↗
- Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. Last author DOI 10.1371/journal.pone.0020143↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Lukasz F. Grochola · 2 shared papers, 2011–2016
- Paper CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1078-0432.ccr-16-0058↗
- Paper Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis i… DOI 10.1097/mpa.0b013e3181f95104↗
- Andrej Udelnow · 2 shared papers, 2011
- Giovanni Stracquadanio · 1 shared paper, 2016
- Pierre-Alain Clavien · 1 shared paper, 2016
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.